ÂÜÀòÂÒÂ×

Sir Keith is one of the UK’s most distinguished clinician-scientists, having previously been Regius Professor of Physic and Head of the School of Clinical Medicine at the University of Cambridge. From 2005-2016 he acted as Senior Consultant in R&D at GSK, reporting to the President of R&D, during which time he also served on GSK’s Global Safety Board. Sir Keith served as a non-executive director on the main board of Amersham plc prior to its £5.7bn acquisition by General Electric in 2003 and chaired the company’s Scientific Advisory Board. He also served on the Medical Advisory Board of Merck Research Laboratories from 1996-2005.